CISATRACURIUM Side Effects

6141645-0 | Anaphylactic Reaction, Breath Sounds Abnormal, Bronchospasm, Peak Expiratory Flow Rate Decreased
on Mar 30, 2009 Male patient from TAIWAN, PROVINCE OF CHINA , 33 years of age, was treated with Cisatracurium (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, breath sounds abnormal, bronchospasm, peak expiratory flow rate decreased. Cisatracurium dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL 25 (View Fentanyl-25 Review and Fentanyl-25 Label ), CEFAZOLIN AND DEXTROSE (View Cefazolin And Dextrose Review and Cefazolin And Dextrose Label ).

6141644-9 | Anaphylactic Reaction, Bronchospasm, Obstructive Airways Disorder, Oedema, Peak Expiratory Flow Rate Decreased
Patient was taking Cisatracurium (View Usage). Patient had the following side effects: anaphylactic reaction, bronchospasm, obstructive airways disorder, oedema, peak expiratory flow rate decreased on Mar 30, 2009 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Male patient , 32 years of age, was diagnosed with anaesthesia and. Cisatracurium dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL 25 (View Fentanyl-25 Review and Fentanyl-25 Label ), CEFAZOLIN AND DEXTROSE (View Cefazolin And Dextrose Review and Cefazolin And Dextrose Label ).

6098890-2 | Acute Coronary Syndrome, Anaphylactic Shock
Adverse event was reported on Feb 20, 2009 by a Male patient taking Cisatracurium (View Usage) (Dosage: ) was diagnosed with endotracheal intubation, anaesthesia and. Location: TAIWAN, PROVINCE OF CHINA , 70 years of age, After Cisatracurium was administered, patient had the following side effects: acute coronary syndrome, anaphylactic shock. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

6087152-5 | Acute Coronary Syndrome, Anaphylactic Reaction, Arteriospasm Coronary, Electrocardiogram St Segment Elevation
on Feb 13, 2009 Female patient from SPAIN , 77 years of age, was diagnosed with induction of anaesthesia and was treated with Cisatracurium (View Usage). Patient experienced the following unwanted or unexpected effects: acute coronary syndrome, anaphylactic reaction, arteriospasm coronary, electrocardiogram st segment elevation. Cisatracurium dosage: .


6038449-6 | Cardio-respiratory Arrest
on Jan 08, 2009 Male patient from UNITED STATES , 41 years of age, was treated with Cisatracurium (View Usage). Patient had the following side effects: cardio-respiratory arrest. Cisatracurium dosage: Route: Ingestion. During the same period patient was treated with SUCCINYLCHOLINE (Route: Ingestion) (View Succinylcholine Review and Succinylcholine Label ), MIDAZOLAM HCL (Route: Ingestion) (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (Route: Ingestions) (View Propofol Review and Propofol Label ), VENLAFAXINE HCL (Route: Ingestion) (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), NEOSTIGMINE (Route: Ingestion) (View Neostigmine Review and Neostigmine Label ).

5363654-1 | Myopathy
Patient was taking Cisatracurium (View Usage). After Cisatracurium was administered, patient had the following side effects: myopathy on Jun 18, 2007 from UNITED STATES Additional patient health information: Male patient , 64 years of age, weighting 172.4 lb, . Cisatracurium dosage: . Patient was hospitalized.

4556154-X | Anaesthetic Complication Neurological
Adverse event was reported on Jan 11, 2005 by a Female patient taking Cisatracurium (View Usage) (Dosage: 4mls) was diagnosed with postoperative analgesia, intubation, abdominal wall operation, epidural anaesthesia, induction of anaesthesia, maintenance of anaesthesia and. Location: , 65 years of age, weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: anaesthetic complication neurological. During the same period patient was treated with LIDOCAINE 2% (2%) (View Lidocaine 2% Review and Lidocaine 2% Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ISOFLURANE (View Isoflurane Review and Isoflurane Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ).